---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-041648"
form_type: "8-K"
ticker: "LNZA"
cik: "0001843724"
company_name: "LanzaTech Global, Inc."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:43:09.612226+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# LanzaTech expands into nutritional protein production from CO2; pre-commercial plant by 2026, commercial by 2028

## Summary
- LanzaTech announces LanzaTech Nutritional Protein (LNP) as primary product using new microbe in gas fermentation.
- Engineering phase for 0.5–1.5 tons/day pre-commercial facility expected operational in 2026.
- First commercial facility (>30,000 MT/yr) targeted for 2028, targeting $1 trillion alternative protein market.
- LNP has complete amino acid profile; GRAS certification for human nutrition underway.
- Partnerships include U.S. Navy Research Lab for military platforms and Mattson for food prototyping.

## SEC filing metadata
- accession: 0001628280-24-041648
- form_type: 8-K
- ticker: LNZA
- cik: 0001843724
- company_name: LanzaTech Global, Inc.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1843724/000162828024041648/0001628280-24-041648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1843724/000162828024041648/amci-20241001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-041648
- JSON: https://secwatch.observer/filing/0001628280-24-041648.json
- Plain text: https://secwatch.observer/filing/0001628280-24-041648.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.